Light Mode
$249.55 ↑ +0.00 (+0.00%) Trading Up from the previous close of $249.55
+29.27 (+13.29%) / 6M
Momentum, market sentiment, and recent alerts
ASND reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +21.3%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.